Stay updated on AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial
Sign up to get notified when there's something new on the AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial page.

Latest updates to the AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, indicating a new internal version of the page rather than substantive content changes.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page’s footer/version identifier has been updated from `Revision: v3.5.2` to `Revision: v3.5.3`, reflecting a site software update rather than any change to the study record.SummaryDifference0.0%

- Check37 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check51 days agoChange DetectedAdded 'Small cell lung carcinoma' to the Conditions list in the study details.SummaryDifference0.0%

- Check66 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0. The study details content and eligibility information appear unchanged.SummaryDifference0.0%

- Check73 days agoChange DetectedFooter now shows Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.0%

Stay in the know with updates to AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial page.